Vimab Group Balance Sheet Health
Financial Health criteria checks 3/6
Vimab Group has a total shareholder equity of SEK68.0M and total debt of SEK118.7M, which brings its debt-to-equity ratio to 174.6%. Its total assets and total liabilities are SEK303.4M and SEK235.4M respectively.
Key information
174.6%
Debt to equity ratio
kr118.68m
Debt
| Interest coverage ratio | n/a |
| Cash | kr14.10m |
| Equity | kr67.98m |
| Total liabilities | kr235.41m |
| Total assets | kr303.38m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: VIMAB's short term assets (SEK138.2M) exceed its short term liabilities (SEK137.8M).
Long Term Liabilities: VIMAB's short term assets (SEK138.2M) exceed its long term liabilities (SEK97.6M).
Debt to Equity History and Analysis
Debt Level: VIMAB's net debt to equity ratio (153.9%) is considered high.
Reducing Debt: Insufficient data to determine if VIMAB's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VIMAB has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: VIMAB has less than a year of cash runway if free cash flow continues to grow at historical rates of 63.7% each year.